BrainStorm secures FDA advisory meeting for ALS drug 28-Mar-2023 By Jane Byrne BrainStorm Cell Therapeutics reports that the FDA is to hold an advisory committee meeting to discuss the company’s BLA for NurOwn, a personalized stem cell treatment targeted at ALS.